Elsevier

American Journal of Otolaryngology

Volume 38, Issue 6, November–December 2017, Pages 654-659
American Journal of Otolaryngology

Original Contribution
Marital status as a predictor of survival in patients with human papilloma virus-positive oropharyngeal cancer,☆☆,

https://doi.org/10.1016/j.amjoto.2017.09.003Get rights and content

Abstract

Purpose

Determine whether marital status is a significant predictor of survival in human papillomavirus-positive oropharyngeal cancer.

Materials and methods

A single center retrospective study included patients diagnosed with human papilloma virus-positive oropharyngeal cancer at Boston Medical Center between January 1, 2010 and December 30, 2015, and initiated treatment with curative intent at Boston Medical Center. Demographic data and tumor-related variables were recorded. Univariate analysis was performed using a two-sample t-test, chi-squared test, Fisher's exact test, and Kaplan Meier curves with a log rank test. Multivariate survival analysis was performed using a Cox regression model.

Results

A total of 65 patients were included in the study with 24 patients described as married and 41 patients described as single. There was no significant difference in most demographic variables or tumor related variables between the two study groups, except single patients were significantly more likely to have government insurance (p = 0.0431). Furthermore, there was no significant difference in 3-year overall survival between married patients and single patients (married = 91.67% vs single = 87.80%; p = 0.6532) or 3-year progression free survival (married = 79.17% vs single = 85.37%; p = 0.8136). After adjusting for confounders including age, sex, race, insurance type, smoking status, treatment, and AJCC combined pathologic stage, marital status was not a significant predictor of survival [HR = 0.903; 95% CI (0.126,6.489); p = 0.9192].

Conclusions

Although previous literature has demonstrated that married patients with head and neck cancer have a survival benefit compared to single patients with head and neck cancer, we were unable to demonstrate the same survival benefit in a cohort of patients with human papilloma virus-positive oropharyngeal cancer.

Introduction

The overall incidence of oropharyngeal cancer (OPSCC) in the United States has not significantly changed between 1974 and 1999; however, there has been a relative increase in OPSCC incidence compared to other head and neck cancers during the same time period [1]. A likely cause of the relative increase in OPSCC is because of the significant increase in human papilloma virus-positive (HPV +) OPSCC, a sexually transmitted disease, and corresponding decrease in HPV − OPSCC, with up to 70% of newly diagnosed cases of OPSCC attributed to HPV [2], [3]. In addition to the increase in incidence of HPV + OPSCC, it is crucial to note that there are significant differences in risk factors [4], [5], [6], [7], [8], [9], prognosis [9], [10], [11], [12], [13], [14], [15], and demographic and pathologic features that are predictive of survival in HPV + OPSCC compared to HPV- OPSCC [12], [15], [16], [17], [18], [19], [20].

Some of the common risk factors described for HPV + OPSCC include number of sexual partners and number of partners for oral sex in comparison to the more traditional risk factors described for HPV − OPSCC including smoking and EtOH [2], [4], [5], [7], [8], [21]. Therefore, a diagnosis of HPV + OPSCC can be considered both an oncologic and psychosocial diagnosis. Multiple studies have looked at the psychological impact of receiving a diagnoses of HPV + OPSCC, and more specifically, Milbury et al. described that approximately 20% of patients reported that the HPV + diagnosis resulted in a negative impact on their relationship, describing reduced trust in the relationship, problems with intimacy, reduced sexual contact, and concerns regarding infidelity [22]. Furthermore, D'Souza et al. interviewed patients receiving treatment for HPV + OPSCC and determined that 5% of patients reported tension with their partners after discussing the HPV status of their tumor [23].

Patients that are diagnosed with HPV + OPSCC are significantly more likely to be married than patients diagnosed with HPV − OPSCC [7], and previous literature has described marital status as a predictor of improved overall survival and earlier stage at diagnosis in both head and neck cancer [24], [25], [26], [27], [28], and in HPV + cervical cancer [29]. However, there is currently no literature looking at whether marital status is a predictor of survival in patients with HPV + OPSCC. As such, we sought to evaluate whether marital status was a significant predictor of survival for patients diagnosed with HPV + OPSCC at a single institution between 2010 and 2015.

Section snippets

Study cohort

Institutional IRB approval was obtained at Boston University Medical Center (BUMC) and determined to be exempt (H-35043). Patients were retrospectively identified for inclusion in the study if they presented with a head and neck tumor and received a diagnostic biopsy with positive P16INK4a immunohistochemistry (IHC) staining between January 1, 2010 and December 30, 2015. Patients were excluded: 1) if the primary site of the cancer was not considered oropharynx, because HPV + cancers in other

Results

A total of 65 patients were included in this study, with 24 patients described as married and 41 patients described as single [single (n = 22), divorced (n = 18), and widow (n = 1)]. The average age at diagnosis for married patients was 62.59 ± 10.04 years compared to 60.57 ± 7.84 for single patients with no significant difference in age between groups (p = 0.3689) (Table 1). The majority of the patients included in this study were male (80.00%) and white race (69.23%), with no significant difference by

Discussion

This was the first study to look at marital status as a predictor of survival in HPV + OPSCC, which may be considered a different disease entity than HPV − OPSCC and other types of head and neck cancer. Our data did not demonstrate a significant difference in overall survival (married = 91.67% vs single = 87.80%; p = 0.6532) or progression free survival (married = 79.17% vs single = 85.37%; p = 0. 8136), even after adjusting for possible confounding factors between married and single patients, which is in

Conclusion

This study demonstrated that there was a significant difference in the type of insurance patients had based on marital status with single patients significantly more likely to have government insurance in comparison to married patients. However, this study did not demonstrate a significant difference in overall survival or disease free survival between married and single patients. Additionally, there was no significant difference in stage at diagnosis when comparing married and single patients,

Acknowledgements

We would like to thank Dr. Ann Marie Egloff, PhD for her guidance throughout this study.

References (42)

  • T. Guo et al.

    Understanding the impact of survival and human papillomavirus tumor status on timing of recurrence in oropharyngeal squamous cell carcinoma

    Oral Oncol

    (2016)
  • C. Fakhry et al.

    Discussing the diagnosis of HPV-OSCC: common questions and answers

    Oral Oncol

    (2013)
  • A.L. Carvalho et al.

    Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database

    Int J Cancer

    (2005)
  • Z. Gooi et al.

    The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer

    Laryngoscope

    (2016)
  • M.L. Gillison et al.

    Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population

    J Clin Oncol

    (2005)
  • C. Schnelle et al.

    Past sexual behaviors and risks of oropharyngeal squamous cell carcinoma: a case-case comparison

    Int J Cancer

    (2016)
  • E. Liederbach et al.

    The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma

    Int J Cancer

    (2016)
  • M.L. Gillison et al.

    Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers

    J Natl Cancer Inst

    (2008)
  • M. Taberna et al.

    Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer

    Cancer

    (2017)
  • K.K. Ang et al.

    Human papillomavirus and survival of patients with oropharyngeal cancer

    N Engl J Med

    (2010)
  • K. Lai et al.

    Differences in survival outcome between oropharyngeal and oral cavity squamous cell carcinoma in relation to HPV status

    J Oral Pathol Med

    (2016)
  • Cited by (5)

    • Does insurance type influence overall survival in patients with laryngeal squamous cell carcinoma?

      2021, American Journal of Otolaryngology - Head and Neck Medicine and Surgery
      Citation Excerpt :

      Additionally, a significant portion of those undergoing chemoradiation present with persistent or recurrent disease, requiring salvage laryngectomy [2]. Socioeconomic factors, such as income and insurance status, play a key role in identifying populations that present with advanced-stage cancers [3–11]. Previous studies have shown that patients with head and neck cancer who are uninsured at diagnosis present at a later stage and with greater tumor burden than those with private insurance [3,6].

    • Factors associated with the quality of life for hospitalized patients with HPV-associated oropharyngeal squamous cell carcinoma

      2020, Oral Oncology
      Citation Excerpt :

      In both HPV-associated cervical cancer and head and neck cancer, the marital status is proved to be a predictor for improved overall survival and earlier stage at diagnosis [18,19]. In HPV-associated OPSCC, married patients are proved to have no survival benefit compared to single patients [20]. We also examined whether the marital status played a function in the regulation of QOL of patients after treatment.

    This research was presented at the AHNS 9th international congress on head and neck cancer on July 16-20, 2016 Seattle, WA.

    ☆☆

    Conflicts of Interest: None.

    Financial Disclosures: None.

    View full text